GJA1 and ischemic cardiomyopathy: Moreover, the effect of CB13 on cellular localization of Cx43 is unknown, though there is some evidence that dexmedetomidine, an α2-agonist with antiarrhythmic properties, increased the distribution of Cx43 in the context of ischemic cardiomyopathy via AMPK activation.